A detailed history of Jeppson Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Jeppson Wealth Management, LLC holds 2,675 shares of AMGN stock, worth $749,187. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,675
Previous 2,684 0.34%
Holding current value
$749,187
Previous $838,000 2.74%
% of portfolio
0.31%
Previous 0.32%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$309.38 - $337.38 $2,784 - $3,036
-9 Reduced 0.34%
2,675 $861,000
Q2 2024

Aug 05, 2024

BUY
$262.75 - $319.31 $70,154 - $85,255
267 Added 11.05%
2,684 $838,000
Q1 2024

Apr 17, 2024

BUY
$268.87 - $324.56 $1,613 - $1,947
6 Added 0.25%
2,417 $687,000
Q4 2023

Jan 11, 2024

BUY
$255.7 - $288.46 $1,278 - $1,442
5 Added 0.21%
2,411 $694,000
Q3 2023

Oct 25, 2023

SELL
$218.65 - $271.46 $2,186 - $2,714
-10 Reduced 0.41%
2,406 $646,000
Q2 2023

Jul 31, 2023

SELL
$214.27 - $253.37 $46,282 - $54,727
-216 Reduced 8.21%
2,416 $536,000
Q1 2023

Apr 27, 2023

SELL
$225.79 - $275.2 $11,063 - $13,484
-49 Reduced 1.83%
2,632 $636,000
Q3 2022

Oct 20, 2022

BUY
$224.46 - $253.15 $11,223 - $12,657
50 Added 1.9%
2,681 $604,000
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $125,967 - $140,180
546 Added 26.19%
2,631 $640,000
Q1 2022

Apr 27, 2022

BUY
$219.27 - $242.57 $12,936 - $14,311
59 Added 2.91%
2,085 $504,000
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $160,695 - $183,900
808 Added 66.34%
2,026 $456,000
Q2 2021

Jul 20, 2021

SELL
$233.58 - $259.14 $1,868 - $2,073
-8 Reduced 0.65%
1,218 $296,000
Q4 2020

Mar 05, 2021

BUY
$216.38 - $257.67 $30,293 - $36,073
140 Added 12.89%
1,226 $282,000
Q3 2020

Nov 19, 2020

BUY
$234.65 - $260.95 $254,829 - $283,391
1,086 New
1,086 $276,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jeppson Wealth Management, LLC Portfolio

Follow Jeppson Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jeppson Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jeppson Wealth Management, LLC with notifications on news.